As of 2026-09-26, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (10.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -214.2%.
The range of the Relative Valuation is (6.03) - (13.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 23.0x | 19.1x |
| Forward P/E multiples | 9.3x - 21.7x | 15.7x |
| Fair Price | (6.03) - (13.53) | (10.85) |
| Upside | -163.5% - -242.4% | -214.2% |
| Date | P/E |